Which medications are commonly targeted for extra safety checks due to high risk of harm?

• A. Antibiotics, anticoagulants, morphine, insulin
• B. Vitamins, minerals, fluids, decongestants
• C. Insulin, heparin, morphine, anticoagulants
• D. Antibiotics, diuretics, analgesics, laxatives

Answer: (C)

High-risk medications are those where errors can cause significant patient harm, so healthcare systems implement extra safety checks for them. The four drugs in this set—insulin, heparin, morphine, and other anticoagulants—are commonly targeted because each has a narrow therapeutic window or a serious potential for harm if misdosed or misused.

Insulin dosing is highly sensitive: small mistakes in concentration, units, or timing can lead to severe hypoglycemia or dangerous hyperglycemia, so explicit verification and careful monitoring are standard practice. Heparin and other anticoagulants carry a major bleeding risk, with doses often adjusted for weight and guided by laboratory tests like INR or aPTT; even minor errors can be life-threatening, prompting rigorous checks, dosing protocols, and monitoring. Morphine, an opioid, has a small margin between effective pain relief and adverse effects such as respiratory depression and oversedation; its dosing, route, and patient response require careful verification and monitoring. Anticoagulants, in general, include several drugs with similar risks, reinforcing the need for independent checks and standard protocols.

While other drug groups—like antibiotics, vitamins/minerals, fluids, decongestants, diuretics, analgesics (outside of opioids), or laxatives—can cause harm, they are not universally designated as high-alert medications requiring the same level of routine extra safety checks in most systems.